Royalty Pharma PLC - Class A

NEW
NAS:RPRX (USA)   Class A
$ 24.84 -0.37 (-1.47%) 11:08 PM EST
9.74
P/B:
1.61
Market Cap:
$ 11.04B
Enterprise V:
$ 17.04B
Volume:
2.54M
Avg Vol (2M):
2.75M
Trade In:
Volume:
2.54M
Avg Vol (2M):
2.75M

Business Description

Royalty Pharma PLC
NAICS : 541714 SIC : 2833
ISIN : GB00BMVP7Y09

Share Class Description:

RPRX: Class A
Description
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Financials (Next Earnings Date:2025-02-14 Est.)

RPRX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RPRX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Royalty Pharma PLC Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2,266.003
EPS (TTM) ($) 2.55
Beta 0.31
3-Year Sharpe Ratio -0.95
3-Year Sortino Ratio -1.1
Volatility % 16.61
14-Day RSI 28.3
14-Day ATR ($) 0.490035
20-Day SMA ($) 26.03
12-1 Month Momentum % -11.53
52-Week Range ($) 24.725 - 31.655
Shares Outstanding (Mil) 444.3

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Royalty Pharma PLC Filings

Filing Date Document Date Form
No Filing Data

Royalty Pharma PLC Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Royalty Pharma PLC Frequently Asked Questions

What is Royalty Pharma PLC(RPRX)'s stock price today?
The current price of RPRX is $24.84. The 52 week high of RPRX is $31.66 and 52 week low is $24.73.
When is next earnings date of Royalty Pharma PLC(RPRX)?
The next earnings date of Royalty Pharma PLC(RPRX) is 2025-02-14 Est..
Does Royalty Pharma PLC(RPRX) pay dividends? If so, how much?
The  Dividend Yield %  of Royalty Pharma PLC(RPRX) is 3.38% (As of Today), Highest Dividend Payout Ratio of Royalty Pharma PLC(RPRX) was 0.55. The lowest was 0.33. And the median was 0.41. The  Forward Dividend Yield % of Royalty Pharma PLC(RPRX) is 3.38%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1